Literature DB >> 20021222

Heat shock proteins and immunity: application of hyperthermia for immunomodulation.

Toshihiko Torigoe1, Yasuaki Tamura, Noriyuki Sato.   

Abstract

Heat shock proteins (HSPs) play an important role as 'endogenous danger signals' in the immune surveillance system. Extracellular HSPs released from damaged cells can stimulate professional antigen-presenting cells, followed by cytokine release and expression of cell surface molecules. In addition to such activity stimulating innate immunity, extracellular HSPs can promote the cross-presentation of HSP-bound peptide antigens to MHC class I molecules in dendritic cells, leading to efficient induction of antigen-specific cytotoxic T-lymphocytes. The roles of HSPs stimulating both innate immunity and adaptive immunity can explain at least in part the molecular mechanism by which thermal stress bolsters the host immune system. In the present review, we present novel aspects of the roles of HSPs in immunity and discuss the therapeutic application of hyperthermia for immunomodulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20021222     DOI: 10.3109/02656730903315831

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  21 in total

1.  Heat shock enhances the expression of cytotoxic granule proteins and augments the activities of tumor-associated antigen-specific cytotoxic T lymphocytes.

Authors:  Akari Takahashi; Toshihiko Torigoe; Yasuaki Tamura; Takayuki Kanaseki; Tomohide Tsukahara; Yasushi Sasaki; Hidekazu Kameshima; Tetsuhiro Tsuruma; Koichi Hirata; Takashi Tokino; Yoshihiko Hirohashi; Noriyuki Sato
Journal:  Cell Stress Chaperones       Date:  2012-07-11       Impact factor: 3.667

Review 2.  Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.

Authors:  Sujatha Muralidharan; Pranoti Mandrekar
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

Review 3.  InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity.

Authors:  Feifan Zhou; Xiaosong Li; Mark F Naylor; Tomas Hode; Robert E Nordquist; Luciano Alleruzzo; Joseph Raker; Samuel S K Lam; Nan Du; Lei Shi; Xiuli Wang; Wei R Chen
Journal:  Cancer Lett       Date:  2015-01-26       Impact factor: 8.679

4.  Effect of interleukin-2 treatment combined with magnetic fluid hyperthermia on Lewis lung cancer-bearing mice.

Authors:  Runlei Hu; Shenglin Ma; Xianfu Ke; Hong Jiang; Dongshan Wei; Wei Wang
Journal:  Biomed Rep       Date:  2015-11-05

5.  An anti-nucleic acid antibody delivers antigen to the cross-presentation pathway in dendritic cells and potentiates therapeutic antitumor effects.

Authors:  Chuong D Pham; Min-Yeong Woo; Yong-Sung Kim; Sun Park; Myung-Hee Kwon
Journal:  J Immunol       Date:  2012-11-14       Impact factor: 5.422

6.  Feasibility and safety assessment of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated mild hyperthermia in pelvic targets evaluated using an in vivo porcine model.

Authors:  Lifei Zhu; Ari Partanen; Michael R Talcott; H Michael Gach; Suellen C Greco; Lauren E Henke; Jessika A Contreras; Imran Zoberi; Dennis E Hallahan; Hong Chen; Michael B Altman
Journal:  Int J Hyperthermia       Date:  2019       Impact factor: 3.914

7.  Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor Vaccine.

Authors:  Feifan Zhou; Jingxuan Yang; Yuqing Zhang; Mingyang Liu; Mark L Lang; Min Li; Wei R Chen
Journal:  Clin Cancer Res       Date:  2018-08-01       Impact factor: 12.531

8.  Haematoporphyrin based photodynamic therapy combined with hyperthermia provided effective therapeutic vaccine effect against colon cancer growth in mice.

Authors:  Yaoming He; Haiyan Ge; Shuping Li
Journal:  Int J Med Sci       Date:  2012-09-19       Impact factor: 3.738

9.  HSP70: an alarmin that does not induce high rates of preterm birth but does cause adverse neonatal outcomes.

Authors:  George Schwenkel; Roberto Romero; Rebecca Slutsky; Kenichiro Motomura; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  J Matern Fetal Neonatal Med       Date:  2020-01-06

Review 10.  Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine.

Authors:  Xiaosong Li; Min Min; Nan Du; Ying Gu; Tomas Hode; Mark Naylor; Dianjun Chen; Robert E Nordquist; Wei R Chen
Journal:  Clin Dev Immunol       Date:  2013-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.